Scidev Ltd - SciDev and Nuoer strike strategic joint venture to accelerate global growth initiatives
Scidev Ltd (ASX:SDV)

SciDev and Nuoer strike strategic joint venture to accelerate global growth initiatives


What's happened?

SciDev Limited (ASX:SDV) and Nuoer have struck a strategic joint venture to accelerate global growth initiatives.

What are the key highlights?

  1. The new JV (Nuoer SciDev JV Co., Ltd (NSC)), provides an excellent platform for SciDev to actively bid on Chinese State-owned and run operations based outside of the PRC that are normally off-limits to western companies (in an estimated USD$10B global chemical market).
  2. NSC, domiciled and headquartered in China, formally brings together the Nuoer Group’s manufacturing and production skills with SciDev’s expert professional services, marketing and sales capacity to jointly engage in developing world-wide business opportunities.
  3. SciDev will continue to explore its own business development opportunities under the existing Heads of Agreement (HoA) which has been expanded and the Nuoer Group will not influence SciDev’s existing operations nor have representation on SciDev’s Board.
  4. In parallel with the new JV, the parties have negotiated two agreements that will be executed in coming weeks. This includes a Licencing and Distribution Agreement (between NSC & Nuoer Group) and a Technical, Marketing and Training Services Agreement (between NSC & SciDev).

For further details relating to the new joint venture, please read the announcement linked below.

What does this announcement mean?

SmallCapInsider from Mawson Graham provides perspective on this recent announcement.
Written by SmallCapInsider
Published Apr 27, 2020

This strategic joint-venture improves upon the existing partnership between SciDev & Nuoer. It solidifies SciDev's ability to continue sourcing PAM from Nuoer, the world's second largest producer, in a cost-effective manner that will help grow both Nuoer Group's and SciDev's businesses. The alignment is highly complimentary; SciDev will continue to focus on its core strength, which is its ability to provide tailor-made solutions for end-users through its strong technical & customer facing team. This point of difference is one of the key reasons behind SciDev's quarter-to-quarter revenue growth as it allows the company to compete against major global chemical companies within its US$10 billion addressable market.

The information within this section has been provided by Mawson Graham Pty Ltd and is for general information purposes only and is not intended to reflect any recommendations or financial advice. The information in this section has been prepared without taking into account your objectives, financial situation or needs. For this reason, you should consider the appropriateness of the advice or recommendation in light of your own personal circumstances, relevant risk factors, the nature and extent of your risk of loss, as well as the legal and accounting consequences before acting making an investment or trading decision regarding any Financial Product mentioned herein. While it is believed that all information sourced and contained within this section to be accurate at the time of publication, liability for any errors, omissions, accuracy or completeness of the information (except any statutory liability which cannot be excluded) is specifically excluded by Mawson Graham Pty Ltd, its associates, officers, directors, employees and agents. Past performance is not a reliable indicator of future performance. Important Disclosure: Mawson Graham Pty Ltd, its directors, associates and employees advise that they may hold securities, may have an interest in and/or earn brokerage, investor relations fees, corporate fees, and other benefits or advantages, either directly or indirectly from client transactions arising from any information mentioned within this section and in documents published within this section.
Mawson Graham
Mawson Graham

Managing Director's Summary

Lewis Utting

"The strategic relationship formed between SciDev and Nuoer in 2019 allowed SciDev access to a world class manufacturing partner. That security of supply, coupled with SciDev’s professional services, know-how and technology has allowed the Company to deliver on our growth ambitions and in parallel support Nuoer in theirs. It is a pleasure to broaden this relationship with Nuoer and the significance of this cannot be understated. The alignment of SciDev’s professional team with the worlds’ second largest producer of our key chemistry, Nuoer, who produce first class product cost effectively creates a potent competitor on the global scene. On behalf of the whole of the SciDev, I look forward to working more closely with Nuoer in this new venture."

Lewis Utting
Managing Director, Scidev Ltd

Download Announcement

View this announcement as well as our full profile on the company.

How do I invest?

Considering investing in Scidev Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:SDV

    On your online investment platform search for the stock ticker code ASX:SDV to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.